The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis

BACKGROUND: Despite emerging treatments for hereditary transthyretin (ATTRv) amyloidosis, the disease is often misdiagnosed, with reported diagnostic delays of up to several years. Knowledge of the patient journey leading up to diagnosis may help to promote earlier intervention. The study’s objectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Vera-Llonch, Montserrat, Reddy, Sheila R., Chang, Eunice, Tarbox, Marian H., Pollock, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798313/
https://www.ncbi.nlm.nih.gov/pubmed/33430941
http://dx.doi.org/10.1186/s13023-020-01623-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798313/
https://www.ncbi.nlm.nih.gov/pubmed/33430941
http://dx.doi.org/10.1186/s13023-020-01623-1

Ejemplares similares